Microvascular insulin resistance with enhanced muscle glucose disposal in CD36 deficiency
Diabetologia · 2025-03 · 68 (3) · 662-675
DOI: 10.1007/s00125-024-06292-4 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Diabetologia, online erschienen am 06.11.2024. Verfasst von Cyndya A Shibao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA. cyndya.shibao@vumc.org. Hauptthemen laut MEDLINE: CD36 Antigens, Glucose, Insulin Resistance, Microvessels. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Aims/hypothesis Microvascular dysfunction contributes to insulin resistance. CD36, a fatty acid transporter and modulator of insulin signalling, is abundant in microvascular endothelial cells. Humans carrying the minor allele (G) of CD36 coding variant rs3211938 have 50% reduced CD36 expression and show endothelial dysfunction. We aimed to determine whether G allele carriers have microvascular resistance to insulin and, if so, how this affects glucose disposal.
Methods
Our multi-disciplinary approach included hyperinsulinaemic–euglycaemic clamps in Cd36 −/− and wild-type mice, and in individuals with 50% CD36 deficiency, together with control counterparts, in addition to primary human-derived microvascular endothelial cells with/without CD36 depletion.
Results
Insulin clamps showed that Cd36 −/− mice have enhanced insulin-stimulated glucose disposal but reduced vascular compliance and capillary perfusion. Intravital microscopy of the gastrocnemius showed unaltered transcapillary insulin flux. CD36-deficient humans had better insulin-stimulated glucose disposal but insulin-unresponsive microvascular blood volume (MBV). Human microvascular cells depleted of CD36 showed impaired insulin activation of Akt, endothelial NO synthase and NO generation. Thus, in CD36 deficiency, microvascular insulin resistance paradoxically associated with enhanced insulin sensitivity of glucose disposal. Conclusions/interpretation CD36 deficiency was previously shown to reduce muscle/heart fatty acid uptake, whereas here we showed that it reduced vascular compliance and the ability of insulin to increase MBV for optimising glucose and oxygen delivery. The muscle and heart respond to these energy challenges by transcriptional remodelling priming the tissue for insulin-stimulated glycolytic flux. Reduced oxygen delivery activating hypoxia-induced factors, endothelial release of growth factors or small intracellular vesicles might mediate this adaptation. Targeting NO bioavailability in CD36 deficiency could benefit the microvasculature and muscle/heart metabolism.
Trial registration
Clinicaltrials.gov NCT03012386 Data availability The RNAseq data generated in this study have been deposited in the NCBI Gene Expression Omnibus ( www.ncbi.nlm.nih.gov/geo/ ) under accession code GSE235988 ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE235988 ). Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA. cyndya.shibao@vumc.org.
- Department of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.
- Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Medicine, Division of Genetic Medicine, Vanderbilt University, Nashville, TN, USA.
- Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Shibao, C. A., Peche, V. S., Pietka, T. A., Samovski, D., Williams, I. M., Abumrad, N. N., Gamazon, E. R., Goldberg, I. J., Wasserman, D. H., & Abumrad, N. A. (2025). Microvascular insulin resistance with enhanced muscle glucose disposal in CD36 deficiency. Diabetologia, 68(3), 662-675. https://doi.org/10.1007/s00125-024-06292-4
Vancouver
Shibao CA, Peche VS, Pietka TA, Samovski D, Williams IM, Abumrad NN, et al. Microvascular insulin resistance with enhanced muscle glucose disposal in CD36 deficiency. Diabetologia. 2025;68(3):662-675. doi:10.1007/s00125-024-06292-4
BibTeX
@article{Shibao2025,
author = {Shibao, Cyndya A and Peche, Vivek S and Pietka, Terri A and Samovski, Dmitri and Williams, Ian M and Abumrad, Naji N and Gamazon, Eric R and Goldberg, Ira J and Wasserman, David H and Abumrad, Nada A},
title = {Microvascular insulin resistance with enhanced muscle glucose disposal in CD36 deficiency},
journal = {Diabetologia},
year = {2025},
volume = {68},
number = {3},
pages = {662--675},
doi = {10.1007/s00125-024-06292-4}
}
EUVIMED